Abstract

Ovarian tissue cryopreservation is the only feasible method for fertility preservation in prepubertal girls that will undergo gonadotoxic chemotherapy. To date, the only clinical use of cryopreserved tissue is by a later tissue retransplantation to the patient. Clinical challenges in fertility preservation of very young patients with cancer include time constraints that do not allow to retrieve the tissue for cryopreservation before starting chemotherapy and the preclusion of future ovarian tissue transplantation due to the risk of reintroduction of malignant cells in patients with systemic diseases. To overcome these two challenges, we investigated using an experimental model the feasibility of retrieving secondary follicles from ovaries of prepubertal mice after cyclophosphamide (CPA) treatment in increasing doses of 50, 75, and 100 mg/kg. The follicles were thereafter cultured and matured in vitro. The main outcomes included the efficiency of the method in terms of obtained matured oocytes and the safety of these potentially fertility preservative procedures in terms of analyses of oocyte competence regarding normality of the spindle and chromosome configurations. Our findings demonstrated that it was feasible to isolate and culture secondary follicles and to obtain mature oocytes from prepubertal mice ovaries recently treated with CPA. The efficiency of this method was highly demonstrated in the 100 mg/kg CPA group, with near 90% follicle survival rate after 12 days’ culture, similarly to control. Around 80% of the follicles met the criteria to put into maturation, and more than 40% of them achieved metaphase II, with normal spindle and chromosome configurations observed. Suboptimal results were obtained in the 50 and 75 mg/kg CPA groups. These paradoxical findings towards CPA dose might probably reflect a more difficult selection of damaged growing follicles from ovaries recently treated with lower doses of CPA and a hampered ability to identify and discard those with reduced viability for the culture.

Highlights

  • Improvements in diagnostic methods allowing early cancer diagnosis and improvements in cancer treatment have both increased cancer patients’ survival rate globally

  • Many young patients need to start a treatment without delay, and data are lacking regarding the usefulness of ovarian tissue retrieved after the chemotherapy rounds have been already initiated

  • This study was designed to investigate the feasibility of obtaining mature oocytes after in vitro culture of follicles isolated from prepubertal mice recently treated with CPA

Read more

Summary

Introduction

Improvements in diagnostic methods allowing early cancer diagnosis and improvements in cancer treatment have both increased cancer patients’ survival rate globally. Efforts have been made to develop methods for fertility preservation, and current guidelines recommend timely discussions with young adult patients, children, and their families on feasible fertility preservative methods as early as possible before the treatment starts aiming at offering the full range of options [2, 3]. Well-established female fertility preservative methods including the cryopreservation of mature oocytes or embryos are available worldwide for adult patients, these are not applicable to young girls. Ovarian tissue cryopreservation can be offered instead in these cases [4]. The method does not require hormonal stimulation, and the tissue is usually retrieved using minimally invasive surgery, which has been reported by programs for fertility preservation [5]. Many young patients need to start a treatment without delay, and data are lacking regarding the usefulness of ovarian tissue retrieved after the chemotherapy rounds have been already initiated

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call